Trial Details

RECRUITING
Basic Information
Clinical ID c347
Identifier NCT05280405
Trial Title Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Infliximab
Participant Information
Sponsor IRCCS Burlo Garofolo
City Trieste
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2022-03-09
Primary Completion Date 2024-01-31
Completion Date 2025-01-31